Username:

Password:
GO
Forgotten your login details? Click here

RECENT TRENDS IN MEDICINAL CHEMISTRY AND ENABLING TECHNOLOGIES
Thursday 5 December 2024
Burlington House, Piccadilly, London W1J 0BQ, UK

Joint meeting with Biological and Medicinal Chemistry Sector of the Royal Society of Chemistry  

OVERVIEW

In December 2024, the Society for Medicines Research and the Biological and Medicinal Chemistry Sector of the Royal Society of Chemistry will be jointly hosting a 1-day meeting in London on Recent Trends in Medicinal Chemistry and Enabling Technologies. The programme will cover a combination of medicinal chemistry, chemistry-based drug discovery enabling technologies and chemical biology.

The meeting will reflect the breadth of work taking place across the UK to advance our understanding and prosecution of targets, technologies and lead series to underpin medicines research.

Here are the confirmed speakers:

  • Alex Baldwin, Cardiff University - Discovery of potent, selective classes of LIMK inhibitors for the treatment of FXS and AML
  • Giorgia Kidd, University of Dundee - Confounding factors in targeted degradation of short lived proteins
  • James Dale, Pharmenable Therapeutics - Reimagining the Drug Discovery Process in the AI Age
  • Steve Howard, Astex Pharmaceuticals - Discovery of ASTX295: A bone-marrow sparing MDM2 Antagonist. From concept to clinic
  • Bill McCoull, AstraZeneca - Optimisation of Potent, Efficacious, Selective and Blood-Brain Barrier Penetrating Inhibitors Targeting EGFR Exon20 Insertion Mutations
  • Jake Bush, GSK - Covalent fragment technologies for therapeutic target discovery and validation
  • Megan St. Denis, Bicycle Therapeutics - Targeted Delivery of Oligonucleotide Therapeutics using BicycleŽ Peptide Technology

OVERVIEW
PROGRAMME